针对心血管疾病患者的自我管理测量仪器:使用COSMIN方法的系统审查协议
Jose Alexandre Barbosa de Almeida1,2, Karolinne Souza Monteiro1,2, Thayla Amorim Santino3
1Faculty of Health Sciences of Trairi, Federal University of Rio Grande do Norte, Santa Cruz, Brazil.
BMJ open
|December 9, 2025
概括
本系统性审查评估了用于心血管疾病自我管理的健康测量工具. 它评估了监测患者健康和改善结果的工具的质量.
科学领域:
- 健康科学 卫生科学 卫生科学
- 临床研究 临床研究
- 患者自我管理
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因.
- 有效的自我管理策略对于预防心血管疾病并发症和改善患者结果至关重要.
- 经过验证的工具对于准确测量自我管理行为至关重要.
研究的目的:
- 系统地审查和评估患者报告的衡量心血管疾病成年人自我管理的仪器的质量.
- 应用基于共识的标准来选择健康测量仪器 (COSMIN) 方法来进行可靠的评估.
- 确定可靠的工具来监测心血管疾病自我管理,并为临床实践提供信息.
主要方法:
- 按照COSMIN指南和系统审查和元分析协议的首选报告项目进行系统审查.
- 在七个主要数据库中进行全面的文献搜索以及对相关网站的手动搜索.
- 包括关于开发和验证患者报告的心血管疾病自我管理工具的研究,没有日期或语言限制.
主要成果:
- 审查将评估所选仪器的心理测量特性和内容.
- 数据提取和质量评估将遵循Cosmin标准.
- 证据质量将使用修改后的推分级,评估,开发和评估方法来确定.
结论:
- 这次审查将对现有的CVD自我管理工具进行批判性评估.
- 结果将指导研究和临床实践的高质量测量工具的选择.
- 这些结果旨在提高心血管保健中自我管理评估的可靠性和有效性.
相关概念视频
Assessment of the Cardiovascular System I: Subjective Data
738
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
738
Cardiomyopathy VI: Nursing Management
299
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
299
Mitral Stenosis IV: Nursing Management
234
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
234
Stress Prevention and Stress Management Techniques I
259
Stress prevention and management are crucial for maintaining well-being and building resilience. Techniques to manage stress include cultivating qualities like conscientiousness, a sense of personal control, and self-efficacy. Each of these traits significantly reduces stress and promotes healthier lifestyle choices and outcomes.
Conscientiousness
Conscientious individuals tend to be organized, responsible, and disciplined. They prioritize completing tasks and following structured routines,...
Conscientiousness
Conscientious individuals tend to be organized, responsible, and disciplined. They prioritize completing tasks and following structured routines,...
259
Atherosclerosis III: Management
296
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296
Cardiomyopathy III: Hypertrophic Cardiomyopathy
374
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374


